A Comprehensive data to Understanding the Molecular Mechanism Involving Breast Cancer

Breast cancer (BC) is the most commonly diagnosed cancer among women excluding nonmelanoma of the skin. It is the second most common cause of death from cancer among women overall. The purpose of this study was to evaluate people’s awareness and knowledge regarding breast cancer. Collectively, parent-inherited gene alterations are thought to be responsible for 5–10% of breast cancer cases. An inherited mutation in either the BRCA1 or BRCA2 gene is the most typical reason for hereditary breast cancer. It also has non-genetic factors including environmental factors. Based on both molecular and histological evidence BC could be categorized into three groups; BC expressing hormone receptor (estrogen receptor (ER+) or progesterone receptor (PR+)), BC expressing human epidermal receptor 2 (HER2+) and triple-negative breast cancer (TNBC) (ER−, PR−, HER2−). Based on a recent study and available data out of one lakh individuals, approximately 35 women were expected to have breast cancer in 2015. Physicians have also noted that women under 40 years of age accounted for 30% of all incidences of breast cancer and this percentage is steadily rising. Main challenges emerging from the healthcare demand worldwide regard long-term care of chronic conditions. TNBCs are a heterogeneous and aggressive form of cancer, for which there are no scientifically validated biologically targeted effective treatments. The lack of ERs, PRs, and HER2 makes finding a reliable treatment alternative for TNBC. some herbal remedies as complementary therapies to manage adverse consequences of cancer therapy, improve their overall well-being, and support their immune system.